Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-11 4:30 pm Unchanged | 2023-10-02 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 8,418,093 30.500% | 0 (Unchanged) | Filing History |
| 2023-10-10 4:30 pm Purchase | 2023-09-28 | 13G | Soleno Therapeutics, Inc. SLNO | Fairmount Funds Management LLC | 950,000 6.200% | 950,000 (New Position) | Filing History |
| 2023-10-06 11:45 am Purchase | 2023-09-26 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 1,459,700 10.100% | 1,459,700 (New Position) | Filing History |
| 2023-10-05 5:09 pm Purchase | 2023-09-26 | 13G | Soleno Therapeutics, Inc. SLNO | RA CAPITAL MANAGEMENT L.P. | 1,233,300 4.600% | 1,233,300 (New Position) | Filing History |
| 2023-10-03 4:05 pm Purchase | 2023-09-28 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,567,247 9.990% | 339,930 (+27.70%) | Filing History |
| 2023-09-28 9:51 pm Purchase | 2023-09-26 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 3,074,542 23.700% | 866,789 (+39.26%) | Filing History |
| 2023-08-30 4:05 pm Purchase | 2023-06-06 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 498,610 4.900% | 76,121 (+18.02%) | Filing History |
| 2023-08-18 4:15 pm Purchase | 2023-08-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,227,317 12.300% | 1,227,317 (New Position) | Filing History |
| 2023-08-15 4:15 pm Unchanged | 2023-08-15 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 2,207,753 22.100% | 0 (Unchanged) | Filing History |
| 2023-06-06 4:17 pm Purchase | 2023-06-02 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 2,207,753 27.000% | 178,298 (+8.79%) | Filing History |
| 2023-06-01 5:00 pm Purchase | 2023-05-25 | 13D | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 8,418,093 50.800% | 8,418,093 (New Position) | Filing History |
| 2023-05-30 4:15 pm Purchase | 2023-05-26 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 2,029,455 24.800% | 85,000 (+4.37%) | Filing History |
| 2023-05-26 1:14 pm Purchase | 2022-11-04 | 13D | Soleno Therapeutics, Inc. SLNO | SCHULER JACK W | 421,976 4.990% | 421,976 (New Position) | Filing History |
| 2023-05-25 4:58 pm Purchase | 2023-05-23 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 1,944,455 23.800% | 80,000 (+4.29%) | Filing History |
| 2023-05-18 4:32 pm Purchase | 2023-05-11 | 13D | Soleno Therapeutics, Inc. SLNO | Perceptive Advisors LLC | 1,864,455 22.800% | 1,864,455 (New Position) | Filing History |
| 2023-05-15 5:02 pm Purchase | 2023-05-08 | 13G | Soleno Therapeutics, Inc. SLNO | Vivo Opportunity Fund Holdings, L.P. | 8,418,093 19.990% | 8,418,093 (New Position) | Filing History |
| 2023-05-10 4:32 pm Unchanged | 2023-05-08 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-15 07:26 am Sale | 2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Orin Hirschman | 422,489 5.200% | -30,844 (-6.80%) | Filing History |
| 2023-02-14 5:06 pm Purchase | 2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 838,534 9.900% | 187,525 (+28.81%) | Filing History |
| 2022-12-20 4:30 pm Sale | 2022-12-16 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 0 0.000% | -1,224,571 (Position Closed) | Filing History |